Čeština | Dansk | Deutsch | English | Español | Français | Italiano | Nederlands | Norsk | Polski | Português | Pусский | Suomi | Svenska | US
Euro Huntington's disease network [logo]
EHDN2016 DISEASE NETWORK REGISTRY PROJECTS LOGIN
 
 
  
Clinical characteristics-other -
--->Uutiset
[+]Projekti
[-]Tutkimuspaikat
--->[+]Itävalta
--->[-]Belgia
--->Coordination
--->HD Associations
--->Antwerpen
--->[+]Bierbeek
--->Brussel - VUB
--->Bruxelles - Saint-Luc
--->Bruxelles - Erasme (UCL)
--->Charleroi
--->Leuven
--->Liège (Luik)
--->[+]Tsekin tasavalta
--->[+]Tanska
--->[-]Suomi
--->Koordinaatio
--->Huntington-yhdistykset
--->Dates
--->Ahvenanmaa
--->Helsinki-HYKS
--->Helsinki-Väestöliitto
--->Kuopio
--->Oulu
--->Tampere
--->Turku-Suvituuli
--->Turku-TYKS
--->[+]Ranska
--->[+]Saksa
--->[+]Ireland
--->[-]Italia
--->Coordination
--->HD Associations
--->Bari
--->Bologna
--->Brescia
--->Cagliari
--->Florence
--->Genoa
--->Milan
--->Napels
--->Pisa
--->Pozzilli
--->Rome
--->Rome-LIRH
--->Rome-Sant'Andrea
--->[+]Alankomaat
--->[+]Norja
--->[+]Puola
--->[+]Portugali
--->[+]Russia
--->[-]Espanja
--->Coordination
--->HD Associations
--->Alicante
--->Badajoz
--->Barcelona - Bellvitge
--->Barcelona - Clinic i Provincia...
--->Barcelona - Mutua de Terra...
--->Barcelona - Santa Creu i Sa...
--->Barcelona - Merced
--->Bilbao
--->Burgos
--->Canaries
--->Granada
--->Fuenlabrada
--->[-]Madrid-BTCIEN
--->[-]Documents
--->Informed Consent
--->ERB
--->Madrid - Clínico
--->Madrid - FJD
--->Madrid - RyC
--->Murcia
--->Oviedo
--->Palma de Mallorca
--->Pamplona
--->Santiago
--->Sevilla
--->Sevilla-HUVRocio
--->Sevilla-St-Ana
--->Valencia
--->Zaragoza
--->[+]Ruotsi
--->[+]Sveitsi
--->[+]Iso-Britannia
--->[+]Outside Europe
[-]Työryhmät
--->[+]Advanced HD
--->[+]Behavioural Phenotype
--->[-]Biological Modifiers
--->Dates
--->[-]Meetings
--->Meeting 2008/04
--->Meeting 2008/09
--->Meeting 2009
--->[+]Biomarkers
--->[+]Brainbanking
--->[+]Cognitive Phenotype
--->[+]Environmental Modifiers
--->[+]Functional Ability
--->[+]Genetic Testing
--->[-]Genetic Modifiers
--->[+]Päivämäärät
--->[-]Meetings
--->Meeting 2005/09
--->Meeting 2006/04
--->Meeting 2008/09
--->Meeting 2009/06
--->Meeting 2012/13
--->[+]Health Economics
--->[+]Imaging
--->[+]Juveniili Huntingtonin tauti
--->[+]Motor Phenotype
--->[+]Neuroprotective Rx
--->[-]Physiotherapy
--->Dates
--->[-]Meetings
--->Meeting 2008/05
--->Meeting 2008/09
--->Meeting 2009
--->Meeting 2012
--->Meeting 2014
--->Meeting 2015
--->Meeting 2016
--->Call 2017 Subgroup Guide...
--->[+]Quality of Life
--->[+]Standard of Care
--->[+]Surgical Therapy
--->[+]Symptomatic Rx
--->[-]Young Adults
--->[+]Dates
--->[-]Meetings
--->Meeting 2009/05
--->Meeting 2009/11
--->Meeting 2010/09
--->Members
[-]Tapahtumat
--->[+]EHDN 2016
--->EHDN 2014
--->[-]EHDN 2012
--->Introduction
--->Announcement
--->Programme Fri
--->Programme Sat
--->Programme Sun
--->Additional Meetings
--->Important Dates
--->Registration
--->[+]Travel & Accommodation
--->[+]EHA Registration
--->EHA Programme
--->Reception Dinner
--->About Stockholm
--->[+]Abstract Submission
--->Reimbursement
--->[-]Documents
--->Handouts
--->Presentations
--->[-]Posters
--->Pathogenic mechanisms
--->Animal models
--->Choreatic disorders - no...
--->Genetic modifiers
--->Wet Biomarkers
--->Imaging
--->Clin characteristics
--->Clin char-motor
--->Clin char-cognitive
--->Clin char - behaviour
--->Clin char-other
--->Clinical studies
--->Genetic testing
--->Clinical care
--->Experimental Rx
--->Clinical Rx
--->Non-scientific
--->Contacts
--->Feedback & Evaluation
--->[+]EHDN 2010
--->[+]EHDN 2008
--->[+]EHDN 2007
--->[+]EHDN 2006
--->[+]EHDN 2005
--->[+]EHDN 2004
[-]Yhteydenpito
--->Yhteydenottolomake
--->Chatti-huoneet
--->Sähköpostilistat - julkinen
--->Newsletter
--->Työtarjoukset
päivämääräkuvauskokokirjoittaja asiakirja 
03.08.26A survey of dietary intake in patients with Huntington`s Disease32 kBanonymousapplication/mswordl03-survey-of-dietary-intake 
03.08.26Insulin sensitivity and early-phase insulin secretion in normoglycemic patients with Huntington’s Disease32 kBanonymousapplication/mswordl02-insulin-sensitivity-insulin-secret... 
03.08.26Sleep in patients with Huntington’s Disease: an interim analysis32 kBanonymousapplication/mswordl01-sleep-in-patients-with-hd 
03.08.26Assessing dysphagia in Huntington’s disease using Fiberoptic Endoscopic Evaluation of Swallowing (FEES)32 kBanonymousapplication/mswordl04-assessing-dysphagia-fees 
03.08.26Summary of carer's views of the decision to insert a percutaneous endoscopic gastrostomy (PEG) feeding tube32 kBanonymousapplication/mswordl05-summary-of-carers-views-peg 
03.08.26The Huntington’s Disease health-related Quality of Life questionnaire (HDQoL): Validation of a disease-specific measure of health-related quality of life32 kBanonymousapplication/mswordl09-validation-of-a-disease-specific-m... 
03.08.26Patient and proxy ratings using the Huntington’s Disease health-related Quality of Life questionnaire (HDQoL)32 kBanonymousapplication/mswordl08-patient-and-proxy-ratings-hdqol 
03.08.26Sexuality in Huntington´s Disease. Introducing a neuro-sexological viewpoint in bio-psycho-social rehabilitation32 kBanonymousapplication/mswordl06-sexuality-in-hd 
03.08.26Huntington's illness: the lived experience of Huntington's Disease32 kBanonymousapplication/mswordl10-the-lived-experience-of-hd 

Kansio sisältää 9 asiakirjaa.
about us | privacy statement | disclaimer | terms of use